These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2930698)

  • 1. The effect of hypobaric hypoxia on misonidazole binding in normal and tumour-bearing mice.
    MacManus MP; Maxwell AP; Abram WP; Bridges JM
    Br J Cancer; 1989 Mar; 59(3):349-52. PubMed ID: 2930698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The labelling of EMT-6 tumours in BALB/C mice with 14C-misonidazole.
    Garrecht BM; Chapman JD
    Br J Radiol; 1983 Oct; 56(670):745-53. PubMed ID: 6616139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Misonidazole binding in murine liver tissue: a marker for cellular hypoxia in vivo.
    Maxwell AP; MacManus MP; Gardiner TA
    Gastroenterology; 1989 Nov; 97(5):1300-3. PubMed ID: 2792663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induced hypoxia in rat pulp and periapex demonstrated by 3H-misonidazole retention.
    Baumgardner KR; Walton RE; Osborne JW; Born JL
    J Dent Res; 1996 Oct; 75(10):1753-60. PubMed ID: 8955670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxic fraction and binding of misonidazole in EMT6/Ed multicellular tumor spheroids.
    Franko AJ
    Radiat Res; 1985 Jul; 103(1):89-97. PubMed ID: 4070561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calibration of misonidazole labeling by simultaneous measurement of oxygen tension and labeling density in multicellular spheroids.
    Gross MW; Karbach U; Groebe K; Franko AJ; Mueller-Klieser W
    Int J Cancer; 1995 May; 61(4):567-73. PubMed ID: 7759162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polarographic measurement of misonidazole in mouse mammary tumors.
    Ohizumi Y; Maezawa H; Murayama C; Mori T
    Tokai J Exp Clin Med; 1984 Aug; 9(3):199-206. PubMed ID: 6537667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution and tumor penetration properties of a radiosensitizer 2-[14C] misonidazole (Ro 07-0582), in mice and rats as studied by whole-body autoradiography.
    Akel G; Benard P; Canal P; Soula G
    Cancer Chemother Pharmacol; 1986; 17(2):121-6. PubMed ID: 3719893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitroimidazole adducts as markers for tissue hypoxia: mechanistic studies in aerobic normal tissues and tumour cells.
    Parliament MB; Wiebe LI; Franko AJ
    Br J Cancer; 1992 Dec; 66(6):1103-8. PubMed ID: 1280990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of 14C-misonidazole to hypoxic cells in V79 spheroids.
    Franko AJ; Chapman JD
    Br J Cancer; 1982 May; 45(5):694-9. PubMed ID: 7082555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of prostaglandin biosynthesis in hypoxic murine mammary adenocarcinoma cells by misonidazole.
    Shalinsky DR; McNamara DB; Agrawal KC
    Cancer Res; 1989 Jul; 49(14):3853-6. PubMed ID: 2736527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of the hypoxia tracer [3H]misonidazole in cerebral ischemia.
    Hoffman JM; Rasey JS; Spence AM; Shaw DW; Krohn KA
    Stroke; 1987; 18(1):168-76. PubMed ID: 3810750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of radiolabeled fluoromisonidazole as a probe for hypoxic cells.
    Rasey JS; Grunbaum Z; Magee S; Nelson NJ; Olive PL; Durand RE; Krohn KA
    Radiat Res; 1987 Aug; 111(2):292-304. PubMed ID: 3628717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Causes of apparent low levels of misonidazole in human tumours.
    Ash DV; Smith MR
    Clin Radiol; 1980 Mar; 31(2):233-7. PubMed ID: 7363558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoradiographic study of tritium-labeled misonidazole in the mouse.
    Cobb LM; Nolan J
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):953-6. PubMed ID: 2703403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anomalous patterns of nitroimidazole binding adjacent to necrosis in human glioma xenografts: possible role of decreased oxygen consumption.
    Parliament MB; Franko AJ; Allalunis-Turner MJ; Mielke BW; Santos CL; Wolokoff BG; Mercer JR
    Br J Cancer; 1997; 75(3):311-8. PubMed ID: 9020473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the biodistribution of two hypoxia markers [18F]FETNIM and [18F]FMISO in an experimental mammary carcinoma.
    Grönroos T; Bentzen L; Marjamäki P; Murata R; Horsman MR; Keiding S; Eskola O; Haaparanta M; Minn H; Solin O
    Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):513-20. PubMed ID: 14722675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypobaric hypoxia: a method for testing bioreductive drugs in vivo.
    McAleer JJ; McKeown SR; MacManus MP; Lappin TR; Bridges JM
    Int J Radiat Oncol Biol Phys; 1992; 23(3):551-5. PubMed ID: 1612955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of 64Cu-ATSM in vitro and in vivo in a hypoxic tumor model.
    Lewis JS; McCarthy DW; McCarthy TJ; Fujibayashi Y; Welch MJ
    J Nucl Med; 1999 Jan; 40(1):177-83. PubMed ID: 9935074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further characterization of 4-bromomisonidazole as a potential detector of hypoxic cells.
    Rasey JS; Krohn KA; Grunbaum Z; Conroy PJ; Bauer K; Sutherland RM
    Radiat Res; 1985 Apr; 102(1):76-85. PubMed ID: 3983371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.